ORAMED PHARMACEUTICALS INC. (ORMP)


Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading ORAMED PHARMACEUTICALS INC. chart...

About the Company

Oramed Pharmaceuticals, or Oramed (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

19

Exchange

Nasdaq

$2M

Total Revenue

19

Employees

$89M

Market Capitalization

9.75

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ORMP News

Oramed Pharmaceuticals Inc ORMP

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Oramed Pharmaceuticals Inc. (ORMP) stock forecast and price target

2y ago, source: Yahoo Finance

Find the latest Oramed Pharmaceuticals Inc. ORMP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Oramed Pharmaceuticals Inc.

3mon ago, source: CNN

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions ...

Oramed Pharmaceuticals Inc. Common Stock (ORMP)

2mon ago, source: Nasdaq

*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces ...

Oramed Pharmaceuticals, Inc

29d ago, source: U.S. News & World Report

Analysts say these cheap stocks have plenty of upside.

Oramed Pharmaceuticals Inc. Common Stock (ORMP)

9y ago, source: Nasdaq

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...

Oramed Pharmaceuticals Inc. (ORMP)

1mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Oramed Pharmaceuticals Inc.

1y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...